After welcoming its first-ever cohort of Master in Finance students on August 26, 2024, the University of Chicago Booth School of Business has received a $60 million gift from Clifford Asness, MBA ’91 ...

It is hard to get excited after looking at Merck's (NYSE:MRK) recent performance, when its stock has declined 13% over the past three months. However, stock prices are usually driven by a company ...

In the most recent MPs register of interests published on Wednesday, the deputy prime minister declared she was given "hospitality - visit to DJ booth, Hi Ibiza, value £836" on 28 August 2024.

In the latest register of MPs’ financial interests revealed on Wednesday, the deputy prime minister declared she received £836 worth of hospitality for a “visit to (a) DJ booth” at ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, will hold its third-quarter 2024 sales and earnings conference call with institutional ...

Nebraska football has 19 commits for the 2025 class at the moment, one of whom is the in-state product Conor Booth. Booth is a three-star in-state running back commit from Bishop Neumann High ...

Merck's Keytruda could face competition from a newer medicine. The company's crown jewel will also lose patent exclusivity in a few years. Merck should have the means to get around these headwinds ...

But we have good shooting. We have really good shooters.” And if that isn’t working, general manager Calvin Booth will be watching closely to determine whether reinforcements are needed.

Merck's combination of a wide lineup of high-margin drugs and a pipeline of new drugs should ensure strong returns on invested capital over the long term. Further, following the divestment of the ...

The agreement grants Merck the option to license Evaxion’s preclinical vaccine candidates EVX-B2 and EVX-B3. Evaxion also granted Merck an option to license preclinical vaccine candidates EVX-B2 ...

Merck & Co. has picked up options on two Evaxion Biotech vaccine candidates, paying $3.2 million and dangling more than $1 billion in milestones for the chance to pick up preclinical prospects ...